http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102300675-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
| filingDate | 2013-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102300675-B1 |
| titleOfInvention | Triazolone compounds and uses thereof |
| abstract | The invention disclosed herein relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, useful for the treatment of prostate cancer, breast cancer, colorectal cancer, pancreatic cancer, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also encompasses pharmaceutical compositions comprising a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof. The invention disclosed herein also relates to methods of treating prostate cancer, breast cancer, ovarian cancer, liver cancer, kidney cancer, colorectal cancer, pancreatic cancer, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein also relates to a method of treating prostate cancer, breast cancer, colorectal cancer, pancreatic cancer, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a therapeutically effective amount of a selective PPARĪ± antagonist. The compounds and pharmaceutical compositions of the present invention are also useful for the treatment of viral infections such as HCV infection and HIV infection. |
| priorityDate | 2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 814.